A Multi-center, Phase III, Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer

Trial Profile

A Multi-center, Phase III, Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer

Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Capecitabine (Primary) ; Antineoplastics
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms MACRO; WUJING
  • Sponsors Roche
  • Most Recent Events

    • 18 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top